Business combinations (Tables)

3 Months Ended

Mar. 31, 2020

Schedule of fair value of assets acquired and liabilities assumed

	Three months ended
	March 31, 2019
Revenue (unaudited)	$	12,908
Pre-tax loss (unaudited)	$	(9,062)

UmanDiagnostics AB Acquisition

Schedule of fair value of consideration transferred

The following table summarizes the preliminary purchase price allocation, net of $1.2 million in cash and cash equivalents acquired (in thousands):

Purchase price:
Cash and stock paid	$	21,217
Cash and cash equivalents acquired		1,221
Purchase price, net		19,996
Assets (liabilities) acquired:
Accounts receivable	$	638
Inventory		1,680
Prepaids and other current assets		114
Property and equipment		33
Intangibles		13,450
Goodwill		8,111
Accounts payable		(20)
Accrued expense and other current liabilities		(871)
Deferred tax liabilities		(3,139)
Total	$	19,996